Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 49.20
+3.45 (7.54%)
Mar 10, 2026, 1:05 PM CST
SHE:002653 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 50,749 | 36,883 | 25,545 | 23,695 | 21,747 | 18,638 | Upgrade
|
| Market Cap Growth | 42.79% | 44.38% | 7.81% | 8.96% | 16.68% | -14.41% | Upgrade
|
| Enterprise Value | 51,663 | 37,658 | 26,256 | 25,227 | 22,521 | 19,066 | Upgrade
|
| Last Close Price | 45.75 | 33.00 | 22.72 | 21.84 | 19.79 | 16.76 | Upgrade
|
| PE Ratio | 167.30 | 93.27 | 86.56 | 85.52 | 63.02 | 29.28 | Upgrade
|
| Forward PE | 97.34 | 58.20 | 62.99 | 69.53 | 62.77 | 23.76 | Upgrade
|
| PS Ratio | 11.88 | 9.91 | 7.61 | 7.86 | 7.84 | 5.60 | Upgrade
|
| PB Ratio | 12.01 | 8.78 | 6.13 | 7.56 | 7.45 | 6.53 | Upgrade
|
| P/TBV Ratio | 19.01 | 12.56 | 7.45 | 10.18 | 10.07 | 8.10 | Upgrade
|
| P/FCF Ratio | 223.29 | 26513.20 | 436.15 | - | - | - | Upgrade
|
| P/OCF Ratio | 79.88 | 83.44 | 56.82 | 250.62 | 607.43 | 90.39 | Upgrade
|
| EV/Sales Ratio | 12.10 | 10.12 | 7.83 | 8.37 | 8.12 | 5.73 | Upgrade
|
| EV/EBITDA Ratio | 106.27 | 75.57 | 48.24 | 79.50 | 122.44 | 57.27 | Upgrade
|
| EV/EBIT Ratio | 231.82 | 143.72 | 79.19 | 178.20 | 598.98 | 83.50 | Upgrade
|
| EV/FCF Ratio | 227.31 | 27070.49 | 448.29 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.46 | 0.43 | 0.67 | 0.43 | 0.38 | Upgrade
|
| Debt / EBITDA Ratio | 4.77 | 3.76 | 3.28 | 6.48 | 6.55 | 3.23 | Upgrade
|
| Debt / FCF Ratio | 10.21 | 1373.28 | 30.84 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.22 | 0.17 | 0.12 | 0.43 | 0.23 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.92 | 1.41 | 0.88 | 4.21 | 3.67 | -0.48 | Upgrade
|
| Net Debt / FCF Ratio | 4.03 | 506.23 | 8.16 | -2.21 | -1.01 | 0.40 | Upgrade
|
| Asset Turnover | 0.61 | 0.55 | 0.53 | 0.55 | 0.56 | 0.66 | Upgrade
|
| Inventory Turnover | 4.10 | 3.84 | 3.10 | 3.05 | 3.91 | 5.17 | Upgrade
|
| Quick Ratio | 1.57 | 1.48 | 1.50 | 1.09 | 0.81 | 1.04 | Upgrade
|
| Current Ratio | 1.76 | 1.74 | 1.76 | 1.38 | 1.02 | 1.22 | Upgrade
|
| Return on Equity (ROE) | 7.36% | 11.14% | 8.09% | 12.94% | 17.93% | 22.98% | Upgrade
|
| Return on Assets (ROA) | 1.97% | 2.44% | 3.26% | 1.60% | 0.47% | 2.84% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.29% | 5.49% | 7.11% | 3.51% | 1.20% | 8.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.10% | 5.00% | 6.40% | 3.10% | 1.10% | 7.00% | Upgrade
|
| Earnings Yield | 0.61% | 1.07% | 1.16% | 1.17% | 1.59% | 3.42% | Upgrade
|
| FCF Yield | 0.45% | 0.00% | 0.23% | -2.56% | -3.07% | -2.12% | Upgrade
|
| Dividend Yield | 0.88% | 1.26% | 0.88% | - | 0.94% | 2.22% | Upgrade
|
| Payout Ratio | 108.47% | 106.72% | 14.43% | 89.32% | 123.52% | 20.54% | Upgrade
|
| Buyback Yield / Dilution | -2.50% | -3.37% | -2.57% | 1.17% | 0.07% | -0.50% | Upgrade
|
| Total Shareholder Return | -1.62% | -2.11% | -1.69% | 1.17% | 1.00% | 1.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.